AXIM Biotechnologies Develops New Dual IgE/MMP-9 Rapid Ophthalmic Diagnostic Test; submits a provisional patent
The company noted in a press release that the test is designed for point-of-care use and will measure IgE and MMP-9 levels in patients, providing results in 10 minutes. The company AXIM Biotechnologies Inc. has filed a patent application with the US Patent and Trademark Office for an innovative new rapid ophthalmic diagnostic solution designed …